Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novavax Inc NVAX

Healthcare Biotechnology
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID... see more

Recent & Breaking News (NDAQ:NVAX)

Novavax Appoints Mark Twyman Vice President Marketing

GlobeNewswire December 21, 2015

Novavax Completes Enrollment of Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults

GlobeNewswire December 14, 2015

Novavax, Inc. : Novavax Completes Enrollment of Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults

Thomson Reuters ONE December 14, 2015

Direction of Market Influences - Research on Depomed, Novavax, Boyd Gaming and Owens-Illinois

Accesswire December 9, 2015

Novavax to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare Conference

GlobeNewswire December 8, 2015

Novavax Initiates Global Pivotal Phase 3 Trial of the RSV F Vaccine to Protect Infants via Maternal Immunization

Thomson Reuters ONE December 3, 2015

Novavax Initiates Global Pivotal Phase 3 Trial of the RSV F Vaccine to Protect Infants via Maternal Immunization

GlobeNewswire December 3, 2015

Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference

Thomson Reuters ONE November 24, 2015

Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 24, 2015

Novavax to Make Multiple Presentations at RSV Vaccines for the World

GlobeNewswire November 16, 2015

Novavax to Present at the Stifel 2015 Healthcare Conference

GlobeNewswire November 10, 2015

Novavax, Inc. : Novavax to Present at the Stifel 2015 Healthcare Conference

Thomson Reuters ONE November 10, 2015

Novavax Reports Third Quarter 2015 Financial Results

GlobeNewswire November 9, 2015

Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults

Thomson Reuters ONE November 9, 2015

Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults

GlobeNewswire November 9, 2015

Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2015

GlobeNewswire November 2, 2015

Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2015

Thomson Reuters ONE November 2, 2015

Novavax Initiates Phase 2 Safety and Immunogenicity Trial to Evaluate Annual Re-Dosing of the RSV F Vaccine in Older Adults

Thomson Reuters ONE October 22, 2015

Novavax Initiates Phase 2 Safety and Immunogenicity Trial to Evaluate Annual Re-Dosing of the RSV F Vaccine in Older Adults

GlobeNewswire October 22, 2015

Novavax Announces Management Promotion

Thomson Reuters ONE October 1, 2015